New cases of mpox reported in Oslo prompt calls for vaccination efforts in Norway

Mpox, formerly known as monkeypox, is a contagious viral disease that is relatively rare in Europe, with a higher prevalence in Africa. It is related to smallpox but is not frequently fatal. Symptoms include rash, fever, muscle aches, and chills.

This week, two new cases of mpox were reported in Oslo, prompting authorities to encourage individuals in at-risk groups—such as men who have sex with men, transgender individuals, and sex workers—to get vaccinated. Critics, however, argue that this response is delayed. Marius Hofseth, president of the fetish and BDSM club Scandinavian Leather Men (SLM), expressed frustration over the lack of timely vaccination efforts since the outbreak began in Norway in 2022.

Hofseth emphasized that despite taking the mpox outbreak seriously, health authorities should have acted sooner. He noted that countries like Germany had already offered drop-in vaccinations as early as spring 2022, while Norway did not begin its vaccination campaign until late summer and fall. This delay allowed the virus to spread.

There are efforts underway in Norway to distribute vaccines more effectively. Those who have had sexual contact with individuals who are suspected or confirmed to have mpox are advised to contact public health authorities within four days for what is called “post-exposure vaccination.”

In Oslo, health officials are prepared to assist an increasing number of individuals needing the vaccine. Concerns remain regarding the lag in vaccination efforts, with many calling for improved communication and accessibility.

The outbreak should serve as a reminder for individuals to remain vigilant about their health, particularly those who attended recent gatherings associated with the confirmed cases. Recommendations include avoiding sexual contact for three weeks after potential exposure and seeking medical attention for any unusual symptoms.